New radiation treatment could spare older women from breast cancer surgery

NCT ID NCT07242118

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a precise, high-dose radiation treatment called SABR as an alternative to surgery for women aged 65 and older with early-stage breast cancer. The goal is to control the cancer while avoiding surgery and maintaining quality of life. Participants will receive five radiation treatments and be monitored for side effects and well-being over one year.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
SABR (stereotactic ablative radiotherapy)
What this could lead to
If successful, this could offer older women with breast cancer a non-surgical treatment option that controls the disease while preserving quality of life.
What could go wrong
This is a small, early-phase study with only 18 participants, so results may not apply to all patients. Radiation side effects are possible, and the treatment may not control the cancer long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Kansas Medical Center

    NOT_YET_RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Kansas Medical Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.